For more information about pregnancy & MS or the Registry please call MS Pathways at: (800) 788-1467 or visit the
MS Pathways website

Increase text size | Decrease text size

At Bayer HealthCare Pharmaceuticals Inc., we are committed to providing the multiple sclerosis (MS) community with information to help ensure the safety of patients. Bayer HealthCare Pharmaceuticals Inc. has established a prospective pregnancy registry to study the maternal and infant pregnancy outcome in women who have taken BETASERON (Interferon beta-1b) at any point around the time of conception or during pregnancy.

This Registry has been established to evaluate the safety of BETASERON use during pregnancy. Information from the Registry may assist clinicians and patients in making an informed decision should exposure to BETASERON occur around the time of conception or while pregnant.

If you are a physician treating a patient of childbearing potential who is taking BETASERON and has become pregnant, you are encouraged to enroll the patient into the registry.

If you are a patient who has taken at least one dose of BETASERON around the time of conception or while pregnant, you can give the Registry permission to contact your healthcare provider

To enroll a patient or yourself into the Registry, please call (800) 478-7049.